1. Home
  2. SION vs OXM Comparison

SION vs OXM Comparison

Compare SION & OXM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SION
  • OXM
  • Stock Information
  • Founded
  • SION 2019
  • OXM 1942
  • Country
  • SION United States
  • OXM United States
  • Employees
  • SION N/A
  • OXM N/A
  • Industry
  • SION
  • OXM Apparel
  • Sector
  • SION
  • OXM Consumer Discretionary
  • Exchange
  • SION NYSE
  • OXM Nasdaq
  • Market Cap
  • SION 564.4M
  • OXM 672.2M
  • IPO Year
  • SION 2025
  • OXM N/A
  • Fundamental
  • Price
  • SION $13.69
  • OXM $53.71
  • Analyst Decision
  • SION Strong Buy
  • OXM Hold
  • Analyst Count
  • SION 1
  • OXM 6
  • Target Price
  • SION $32.00
  • OXM $58.40
  • AVG Volume (30 Days)
  • SION 143.7K
  • OXM 376.5K
  • Earning Date
  • SION 05-12-2025
  • OXM 06-11-2025
  • Dividend Yield
  • SION N/A
  • OXM 5.14%
  • EPS Growth
  • SION N/A
  • OXM 53.66
  • EPS
  • SION N/A
  • OXM 5.87
  • Revenue
  • SION N/A
  • OXM $1,516,601,000.00
  • Revenue This Year
  • SION N/A
  • OXM N/A
  • Revenue Next Year
  • SION N/A
  • OXM $2.59
  • P/E Ratio
  • SION N/A
  • OXM $9.14
  • Revenue Growth
  • SION N/A
  • OXM N/A
  • 52 Week Low
  • SION $7.26
  • OXM $42.12
  • 52 Week High
  • SION $25.19
  • OXM $111.44
  • Technical
  • Relative Strength Index (RSI)
  • SION N/A
  • OXM 48.50
  • Support Level
  • SION N/A
  • OXM $52.45
  • Resistance Level
  • SION N/A
  • OXM $56.22
  • Average True Range (ATR)
  • SION 0.00
  • OXM 1.77
  • MACD
  • SION 0.00
  • OXM -0.13
  • Stochastic Oscillator
  • SION 0.00
  • OXM 15.97

About SION SIONNA THERAPEUTICS INC

Sionna Therapeutics Inc is a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF) patients by developing novel medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator (CFTR) protein to deliver clinically meaningful benefit to CF patients. CF is a progressive and life-threatening genetic disease caused by inherited mutations in the CFTR gene, which heads to insufficient CFTR function. The Company is managed as one operating segment focused on the research and development of cystic fibrosis therapies.

About OXM Oxford Industries Inc.

Oxford Industries Inc is an apparel manufacturing company that designs, sources, markets, and distributes products under the brand name Tommy Bahama, and Lilly Pulitzer. Tommy Bahama designs, sources, markets, and distributes men's and women's sportswear and related products. Lilly Pulitzer designs, sources, markets, and distributes upscale collections of women's and women's dresses, sportswear, and related products. The company generates majority of its revenue from the Tommy Bahama division.

Share on Social Networks: